These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31933285)

  • 21. Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR.
    Benston S
    J Med Ethics; 2017 Dec; 43(12):819-823. PubMed ID: 28473627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome editing in the mammalian brain using the CRISPR-Cas system.
    Nishiyama J
    Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heritable Human Genome Editing: The Public Engagement Imperative.
    Adashi EY; Burgess MM; Burall S; Cohen IG; Fleck LM; Harris J; Holm S; Lafont C; Moreno JD; Neblo MA; Niemeyer SJ; Rowe EJ; Scheufele DA; Tetsa PF; Vayena E; Watermeyer RP; Fung A
    CRISPR J; 2020 Dec; 3(6):434-439. PubMed ID: 33346718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Justice in CRISPR/Cas9 Research and Clinical Applications.
    Hildebrandt CC; Marron JM
    AMA J Ethics; 2018 Sep; 20(9):E826-833. PubMed ID: 30242813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9 and the Promise of a Better Future.
    Raposo VL
    Eur J Health Law; 2019 Oct; 26(4):308-329. PubMed ID: 31597119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethics assessment in research proposals adopting CRISPR technology.
    Hirsch F; Iphofen R; Koporc Z
    Biochem Med (Zagreb); 2019 Jun; 29(2):020202. PubMed ID: 31223254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procreative Non-Maleficence: A South African Human Rights Perspective on Heritable Human Genome Editing.
    Thaldar D; Shozi B
    CRISPR J; 2020 Feb; 3(1):32-36. PubMed ID: 32091250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The better edge of the CRISPR blade.
    The Lancet
    Lancet; 2020 Jan; 395(10218):90. PubMed ID: 31929016
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human genome editing: ask whether, not how.
    Hurlbut JB
    Nature; 2019 Jan; 565(7738):135. PubMed ID: 30602779
    [No Abstract]   [Full Text] [Related]  

  • 39. Legality of Embryonic Gene Editing in Australia.
    Taylor-Sands M; Gyngell C
    J Law Med; 2018 Dec; 26(2):356-373. PubMed ID: 30574724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene editing for cell engineering: trends and applications.
    Gupta SK; Shukla P
    Crit Rev Biotechnol; 2017 Aug; 37(5):672-684. PubMed ID: 27535623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.